What does dorzolamide do to the eye?

What does dorzolamide do to the eye?

Ophthalmic dorzolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Dorzolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.

What are the side effects of dorzolamide eye drops?

Side Effects Temporary blurred vision, temporary burning/stinging/itching/redness of the eye, watery eyes, dry eyes, sensitivity of eyes to light, bitter taste, or headache may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

How long does it take for dorzolamide to work?

Give this medication at least 5 minutes apart from other medications used in the eye. This medication should take effect within 1 to 2 hours; however, effects may not be visibly obvious and therefore laboratory tests may need to be done to evaluate this medication’s effectiveness.

What is dorzolamide HCL timolol maleate ophthalmic solution used for?

The combination of dorzolamide and timolol is used to treat eye conditions, including glaucoma and ocular hypertension, in which increased pressure can lead to a gradual loss of vision. Dorzolamide and timolol is used for patients whose eye condition has not responded to another medication.

Does dorzolamide cause hair loss?

Hair loss is found among people who take Dorzolamide hydrochloride, especially for people who are female, 60+ old also take medication Adcal, and have Intraocular pressure increased.

Is dorzolamide a beta blocker?

Dorzolamide/timolol, sold under the brand name Cosopt among others, is a medication used to treat high pressure inside the eye including glaucoma. It is a combination of dorzolamide hydrochloride and timolol maleate. It may be used when a beta blocker, like timolol , is not sufficient alone. It is used as an eye drop.

What is dorzolamide hydrochloride?

Dorzolamide Description. Dorzolamide hydrochloride ophthalmic solution, USP is a carbonic anhydrase inhibitor formulated for topical ophthalmic use. Dorzolamide hydrochloride, USP is described chemically as: (4S, 6S)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide monohydrochloride.

About the Author

You may also like these